HURA
TuHURA Biosciences, Inc.
There isn't enough reported data to score HURA yet.
HURA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
HURA's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
HURA PE Valuation
HURA has no meaningful PE right now: it lost money over the past year.
HURA Forward outlook
There aren't enough analyst estimates for HURA to show an outlook.
HURA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.54 | +$1.33 |
HURA lost $0.54 per share over the past year, a smaller loss than the year before.
HURA Quarterly Revenue
HURA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$8.8M | -$2.5M |
| Q1 2026 | -$4.5M | +$319.3K |
| Q4 2025 | -$5.6M | -$3M |
| Q3 2025 | -$11.1M | -$9.2M |
| Q2 2025 | -$6.3M | -$4.8M |
| Q1 2025 | -$4.8M | -$2.5M |
| Q4 2024 | -$2.6M | -$504K |
| Q3 2024 | -$1.9M | -$572K |
HURA has burned cash in almost every quarter: −$30M over the past year, against −$16M the year before.
HURA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.6% | +4M shares |
| 1 year | +47% | +20.6M shares |
| 3 years | +136158% | +63.9M shares |
| 5 years | +980334% | +64M shares |
HURA has 64M diluted shares, up 47% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
HURA Net Leverage
HURA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HURA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.7 | Neutral |
| Stochastic | 12.9 | Oversold |
HURA's weekly RSI is 40 (neutral) and its Stochastic is 13 (oversold).
HURA PE vs Healthcare Sector
HURA has no meaningful PE right now: it lost money over the past year.
HURA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.86 | 22% below |
| 20 week MA | $2.06 | 30% below |
| 50 week MA | $1.82 | 20% below |
| 100 week MA | $2.47 | 41% below |
| 200 week MA | $32.5 | 96% below |
HURA is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
HURA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,032.5 | $2,397.5 | +132% |
| 2021 | $2,397.5 | $1,050.0 | -56% |
| 2022 | $1,050.0 | $296.8 | -72% |
| 2023 | $296.8 | $5.95 | -98% |
| 2024 | $5.95 | $4.41 | -26% |
| 2025 | $4.41 | $0.80 | -82% |
| 2026 YTD | $0.80 | $1.45 | +81% |
HURA has finished five years in a row lower, and it's up 81% so far in 2026.